Evaluation of injection force of three insulin delivery pens

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 9, 2009, Pages 1389-1393

  Asakura, T ^a   Seino, H ^b   Kageyama, M ^a   Yohkoh, N ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b Seino Clinic   (Japan)

Author keywords

Injection force; Insulin pen; KwikPen; Next generation FlexPen; SoloStar

Indexed keywords

INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FORCE; INJECTION; INSULIN DELIVERY PEN; NEEDLE;

DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; EQUIPMENT SAFETY; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; SELF ADMINISTRATION;

EID: 67650690843     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560903018929     Document Type: Article

References (29)

1. Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74 (Pubitemid 38112268)
2. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type1 diabetes. Diabetes Care 1999;22:137-140 (Pubitemid 29028310)
3. Coscelli C, Lostia S, Lunetta M, et al. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:173-177
4. Asakura T. Comparison of the dosing accuracy of two insulin injection devices. J Clin Res 2005;8:33-40 (Pubitemid 43041653)
5. Asakura T, Seino H. Insulin dosing accuracy with FlexPen® versus syringe by healthcare professionals and healthy volunteers. Diabetes 2005;54:A498-9
6. Asakura T, Seino H, Kageyama M, et al. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opinion 2008;24:429-434 (Pubitemid 351741576)
7. Hänel H, Weise A, Sun W, et al. Differences in the dose accuracy of insulin pens. J Diabetes Sci Tech 2008;2:478-481
8. Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versusa vial and syringe. Clin Ther 1998;20:486-496 (Pubitemid 28343501)
9. Korytkowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-2848 •• A well-designed trial demonstrating the patient preference for insulin pens over vial and syringe.
10. Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-1505 (Pubitemid 39572159)
11. Albano S. Assessment of quality of treatment in insulin-treated patients with diabetes using a pre-filled insulin pen. The ORBITER Study Group. Acta Biomed 2004;75:34-39
12. Thurman JE. Insulin pen injection devices for management of patients with type2 diabetes: considerations based on an endocrinologist's practical experience in the United States. Endocr Pract 2007;13:672-678
13. Stockl K, Ory C, Vanderplas A, et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007;23:133-146 (Pubitemid 46191679)
14. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-2497 (Pubitemid 39281409)
15. Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-1725 (Pubitemid 44841979)
16. Pawaskar MD, Camacho FT, Anderson RT, et al. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type2 diabetes: a retrospective database analysis. Clin Ther 2007;29:1294-1305
17. Lombardo F, Salzano G, Messina MF, et al. Compliance and administration methods in management of type 1 diabetes. Acta Biomed 2005;76(Suppl 3):66-69 (Pubitemid 351767168)
18. Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: How well do adults follow prescriptions for insulin? Diabetes Care 2005;28:78-83
19. Donnelly LA, Morris AD, Evans JM. Adherence to insulin and its association with glycaemic control in patients with type2. diabetes QJM 2007;100:345-350
20. Morris AD, Boyle DI, McMahon AD, et al. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 1997;350:1505-1510
21. Frey MI, Barrett-Connor E, Sledge PA, et al. The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J Rheumatol 1996;23:716-722 (Pubitemid 26132859)
22. Savas S, Koroglu BK, Koyuncuoglu HR, et al. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type2 diabetic patients. Diabetes Res Clin Pract 2007;77:77-83 •• Discusses the reduce hand-strength in some patients with diabetes, which may influence patient preference for lower injection force devices.
23. Schady W, Abuaisha B, Boulton AJ. Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications 1998;12:128-132 (Pubitemid 28241436)
24. Starkman HS, Gleason RE, Rand LI, et al. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications. Ann Rheum Dis 1986;45:130-135 (Pubitemid 16162480)
25. Ziegler D, Gries FA, Spuler M, et al. The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med 1993;10(Suppl 2):82S-6S
26. Sommavilla B, Jorgensen C, Jensen KH. Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2223-2232
27. Pfützner A, Reimer T, Frokjaer LPF, et al. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:2545-2549 •• First report on Next Generation FlexPen, which shows the reduced injection force compared with FlexPen and patient perception of the two pens.
28. Rissler J, Jorgensen C, Rye Hansen M, et al. Evaluation of injection force dynamics of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2217-2222 •• Demonstrates the reduced injection force of Next Generation FlexPen compared with SoloStar.
29. Weise A, Pfutzner JW, Borig J, et al. Comparison of the dose accuracy of prefilled insulin pens. J Diabetes Sci Tech 2009;3:149-153